Please login to the form below

Not currently logged in
Email:
Password:

Batten disease

This page shows the latest Batten disease news and features for those working in and with pharma, biotech and healthcare.

NICE approves BioMarin’s Brineura after initial setback

NICE approves BioMarin’s Brineura after initial setback

First treatment for rare disease. BioMarin and NICE had a rocky start with Batten disease therapy Brineura, but the two have now come to an agreement. . ... The disease, known as neuronal ceroid lipfuscinosis type 2 (CLN2), is a very rare inherited

Latest news

  • BioMarin ticks over in Q2 ahead of gene therapy filing BioMarin ticks over in Q2 ahead of gene therapy filing

    A second-generation treatment for rare disease phenylketonuria (PKU), the newly launched drug reported $18.8m in sales. ... BioMarin will also hope to extend the commercial success of Brineura, its Batten disease therapy.

  • Amicus forms gene therapy manufacturing partnership with Catalent Amicus forms gene therapy manufacturing partnership with Catalent

    Amicus has one rare disease medicine already on the market, Galafold for Fabry disease, with an enzyme replacement therapy (AT-GAA) for Pompe disease in its late stage pipeline, to which ... capabilities. Thermo Fisher will supply Amicus with immediate

  • NICE knocks back BioMarin’s Batten disease drug NICE knocks back BioMarin’s Batten disease drug

    The committee initially agreed that Brineura shows substantial short-term benefits in slowing down the rate of Batten disease progression in draft guidance, but said BioMarin was unable to price the ... Results from a phase 1 and 2 clinical trial show

  • CHMP backs two rare disease therapies at April meeting CHMP backs two rare disease therapies at April meeting

    BioMarin got a green light for Brineura (cerliponase alfa), an enzyme replacement therapy for the ultra-rare neurodegenerative disease neuronal ceroid lipofuscinosis type 2 (CLN2), a form of Batten disease that ... There is no approved drug to treat the

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...
The era of digital wellbeing
Social media - friend or foe?...

Infographics